1 month ago
Delhi HC Examines PIL on HPV Vaccination Programme
The Delhi High Court is looking into a complaint about the government's plan to give HPV vaccines to teenage girls.
The complaint says the vaccines are being given without proper permission from parents and without enough information about their safety.
The court wants the government to provide data on any bad reactions to the vaccine.
The complaint also mentions some girls who had serious health problems after getting the vaccine.
The court will decide if the vaccination programme should continue as it is or if changes need to be made.
The Delhi High Court agreed to examine a PIL challenging the HPV vaccination programme for adolescent girls.
The court directed the Union government to provide data on adverse events following HPV vaccination.
The petition alleges that the vaccine is being administered without proper informed consent or prior approval from parents.
The petition cites cases of severe neurological symptoms in girls after receiving the HPV vaccine.
The petition argues that compulsory vaccination violates the constitutional rights of bodily integrity and personal autonomy.
- Who
- Delhi High Court, Union Government, Petitioners (Rohit Kumar)
- What
- Examination of a PIL challenging the HPV vaccination programme for adolescent girls
- Where
- Delhi High Court, New Delhi
- When
- Wednesday (specific date not mentioned)
- Why
- To address concerns over the HPV vaccination programme, including informed consent, safety, and efficacy
Petitioners
Government and Health Authorities
Informed Consent
Petitioners
The petitioners argue that the HPV vaccine is being administered without proper informed consent or prior approval from parents, violating the constitutional rights of young girls.
Government and Health Authorities
The government and health authorities maintain that the vaccination programme is implemented with necessary protocols and consent procedures.
Safety and Efficacy
Petitioners
The petitioners question the safety and efficacy of the HPV vaccine, citing adverse events and lack of credible data.
Government and Health Authorities
The government and health authorities assert that the vaccine is safe and effective, backed by scientific evidence and international health standards.
Key facts
- Court
- Delhi High Court
- Petitioners
- Rohit Kumar (Advocate)
- Respondents
- Union Government
- Vaccine in Question
- Gardasil (HPV Vaccine)
- Target Group
- Adolescent girls aged around 14 years
- Programme
- Universal Immunisation Programme (UIP)
- Key Concerns
- Informed consent, safety, efficacy, and public health priorities
Quotes
The petitioner
Advocate Rohit Kumar representing the PIL
“"The entire programme has been launched without any credible data with respect to the efficacy of the vaccine and the actual requirement of the population"”
thehansindia.com
Sources
Related news
Seven AI Courses Offer Paths From Free Lessons to Credentials
Reliance Explores Aluminium Production Through Odisha Bauxite and Coal Gasification
Bengaluru Engineers Develop Affordable AI PC KEO
Scientists discover brain 'brake' for chronic pain
Reliance Explores Aluminium as Ambani-Adani Rivalry Expands
Vijayawada to Get South Coast Railway's First Kavach Network
Pregnant Inmates in Madhya Pradesh Jails Struggle to Access Release
Two Women Allegedly Assault Colleague In Gwalior Street Fight
Supreme Court Quashes FIRs Against 15 CJP Activists
Bhopal GRP Recovers ₹62.26 Lakh in Train Theft Crackdown
Four Killed, Two Critically Injured in Ashoknagar Bike Crash
